Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Mesoblast Reports Net Loss of $50.24m for Half-Year to 31 December 2020

05 Apr 2021  |  19:42:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Half Year Report and Accounts (including Appendix 4D)

Mesoblast reported net loss of $50.24m for the half-year ended 31 December 2020. Revenue from ordinary activities were $3.54m. Basic and Diluted EPS were (8.6) cents compared to (5.82) cents last year. The net operating cash outflow was $60.13m compared to an outflow of $16.89m in the pcp. No dividend was declared.

Mesoblast Half Year Results to 31 December 2020

6 Months to 31 December 2020 ($US'000) 6 Months to 31 December 2019 ($US'000)
Revenue 3,546 19,254
Pre-Tax Profit (Loss) (50,892) (34,269)
Net Profit (Loss) (50,236) (30,067)
Operating Cash Flow (60,129) (16,888)
Interim Dividends (cents) nil nil
Basic and Diluted EPS (cents) (8.6) (5.82)
NTA (cents) (7.09) (6.49)
Please click here for full details

See more ASX300 News Announcements